Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome
| Autor: | Deirdre Walsh, Hiba M. Shendi, J. David M. Edgar |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty Time Factors Fever Immunology Receptors Tumor Necrosis Factor Etanercept Rheumatology Internal medicine medicine Immunology and Allergy Humans In patient Adverse effect Child Anakinra Mevalonate kinase deficiency business.industry Tumor Necrosis Factor-alpha medicine.disease Dermatology Thalidomide Interleukin 1 Receptor Antagonist Protein Treatment Outcome Antirheumatic Agents Immunoglobulin G Female Mevalonate Kinase Deficiency Periodic fever syndrome business medicine.drug |
| Zdroj: | Rheumatology international. 32(1) |
| ISSN: | 1437-160X |
| Popis: | Hyperimmunoglobulin D and periodic fever syndrome (HIDS) is a rare, hereditary autoinflammatory condition, characterized by recurrent inflammatory episodes. There is no proven treatment for HIDS, but various drugs including, non-steroidal anti-inflammatory drugs, colchicine, steroids, statins and thalidomide have all been tried. Recently, some patients have demonstrated a good clinical response to either etanercept or anakinra. We report a case of a 10-year-old girl who experienced prolonged and severe inflammatory attacks, when she was treated with etanercept, and later with anakinra. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink